tiprankstipranks

Scott Tarriff Insider Profile

4 Followers
Scott Tarriff, Ten Percent Owner at Eagle Pharmaceuticals, holds 1.45M shares in Eagle Pharmaceuticals (Ticker: EGRX), holds 0.00 shares in Theriva Biologics (Ticker: TOVX), holds 4.19K shares in Alaunos Therapeutics (Ticker: TCRT).
tipranks
Scott Tarriff

Scott Tarriff
Eagle Pharmaceuticals (EGRX)
Ten Percent Owner

Ranked #11,251 out of 98,624 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+45.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
99.91%
0.09%
0.00%
A breakdown of Scott Tarriff's holdings

Insider Roles

Eagle Pharmaceuticals
(EGRX)
Ten Percent Owner
Alaunos Therapeutics
(TCRT)
Director
Theriva Biologics
(TOVX)
Former Director
Roles that Scott Tarriff holds in companies

Most Profitable Insider Trade

Stock:
Eagle Pharmaceuticals
(EGRX)
Rating:Informative Sell
Date:May 15, 2023 - Today
Return:+80.20%
The most profitable trade made by Scott Tarriff

Scott Tarriff's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eagle Pharmaceuticals
Mar 01, 2024
Ten Percent Owner
Uninformative Sell
13.29K
$6.05M
Alaunos Therapeutics
Sep 29, 2015
Director
Uninformative Buy
$5.53K
Theriva Biologics
Nov 18, 2016
Former Director
Uninformative Buy
$0.00
List of latest transactions for each holding click on a transaction to see Scott Tarriff's performance on stock

Scott Tarriff insider profile FAQ

What is the percentage of profitable transactions made by Scott Tarriff?
The percentage of profitable transactions made by Scott Tarriff is 75%.
    What is the average return per transaction made by Scott Tarriff?
    The average return per transaction made by Scott Tarriff is 45.70%.
      What stocks does Scott Tarriff hold?
      Scott Tarriff holds: EGRX, TCRT, TOVX stocks.
        What was Scott Tarriff’s latest transaction?
        Scott Tarriff latest transaction was an Uninformative Sell of $13.29K.
          What was Scott Tarriff's most profitable transaction?
          Scott Tarriff’s most profitable transaction was an Informative Sell of EGRX stock on May 15, 2023. The return on the trade was 80.20%.
            What is Scott Tarriff's role in Eagle Pharmaceuticals?
            Scott Tarriff's role in Eagle Pharmaceuticals is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.